miR‐155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group

Abstract

High miR-155 expression is an adverse prognostic factor in pediatric NK-AML patients. Specifically, high miR-155 expression not only correlates with FLT3/ITD mutation status and high-risk disease but it is also an independent predictor of worse EFS and OS.